FIELD: bioengineering.
SUBSTANCE: strain ensures destruction of the biofilms created by bacteria of Staphylococcus family, and contains gene coding the alpha-subunit of ribonucleotide reductase 1b. Strain is deposited in Collection of bacteria, bacteriophages and fungi at FBIS SSC VB Vector under No. Ph-1312.
EFFECT: bacteriophage strain has wide spectrum of lytic activity in relation to test-strains and clinic isolates of bacteria of Staphylococcus family, and can be used during creation of germicides resulting in death of bacteria of Staphylococcus family.
7 dwg, 1 tbl, 8 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| RECOMBINANT PLASMID DNA pQE-60_LysSte134, PROVIDING SYNTHESIS OF RECOMBINANT PROTEIN LysSte134, BACTERIAL STRAIN ESCHERICHIA COLI - PRODUCER OF RECOMBINANT PROTEIN LysSte134 AND RECOMBINANT PROTEIN LysSte134, HAVING ANTIBACTERIAL ACTION | 2024 | 
 | RU2829504C1 | 
| RECOMBINANT PLASMID DNA pQE-70_LysAP46 PROVIDING SYNTHESIS OF RECOMBINANT PROTEIN LysAP46, STRAIN OF ESCHERICHIA COLI BACTERIA - PRODUCER OF RECOMBINANT PROTEIN LysAP46 AND RECOMBINANT PROTEIN LysAP46, WHICH HAS ANTIBACTERIAL EFFECT | 2022 | 
 | RU2809842C1 | 
| BIOFILM PREVENTION, DESTRUCTION AND TREATMENT BY BACTERIOPHAGE LYSIN | 2013 | 
 | RU2646102C2 | 
| PREVENTION, DESTRUCTION AND TREATMENT OF BIOFILM BY BACTERIOPHAGE LYSINE | 2013 | 
 | RU2735103C2 | 
| SPECIES-SPECIFIC BACTERIOPHAGE STRAIN HAVING LYTIC ACTIVITY IN RELATION TO Staphylococcus aureus, INCLUDING MULTI-DRUG RESISTANT STRAINS | 2012 | 
 | RU2503716C1 | 
| STRAIN OF BACTERIOPHAGE Citrobacter freundii CF17 ABLE TO LYSE PATHOGENIC STRAINS CITROBACTER FREUNDII | 2014 | 
 | RU2565559C1 | 
| METHOD OF EXTRACTING VIRULENT BACTERIOPHAGES STAPHYLOCOCCUS AUREUS | 2020 | 
 | RU2738743C1 | 
| STAPHYLOCOCCUS AUREUS BACTERIA STRAIN "SAU-21L" FOR PRODUCTION OF BIOPREPARATIONS FOR SPECIFIC PREVENTION OF COW MASTITIS | 2023 | 
 | RU2820305C1 | 
| METHOD FOR SELECTION OF POTENTIAL PROBIOTICS EFFECTIVE AGAINST STAPHYLOCOCCUS AUREUS | 2020 | 
 | RU2780208C2 | 
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE INFECTIONS CAUSED BY METICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS, WHICH INCLUDES AS ACTIVE INGREDIENT N-TERMINAL CHAP-DOMAIN OF ENDOLYSIN OF BACTERIOPHAGE K STAPHYLOCOCCUS AUREUS | 2019 | 
 | RU2715694C1 | 
Authors
Dates
2015-10-20—Published
2014-11-19—Filed